-+ 0.00%
-+ 0.00%
-+ 0.00%
Charles River Laboratories International Reiterates FY26 Revenue, Non-GAAP Earnings Outlook, Expects FY30 Organic Revenue Growth In Range Of 5% To 7%
Share
Listen to the news

Charles River Laboratories International, Inc. (NYSE: CRL) will host its 2026 Investor Day today, September 24, 2026, starting at 9:00 a.m. ET.

The Company is also introducing the following long-term financial targets through 2030:

  2026
GUIDANCE(1)
2030
TARGET(2)
Revenue growth, organic (3) Upper end of
0% – 1% growth
5% – 7%
2027-2030 CAGR
Non-GAAP operating margin (4) 21.0% – 21.3% ~24%
Non-GAAP EPS estimate (4) Upper end of
$11.15 – $11.45
Low-double-digit
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending